img

Global Neuroprotective Products Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neuroprotective Products Market Insights, Forecast to 2034

Neuroprotective Products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions. 
Global Neuroprotective Products market is expected to reach to US$ 23700 million in 2024, with a positive growth of %, compared with US$ 24190 million in 2022. Backed with the increasing demand from downstream industries, Neuroprotective Products industry is evaluated to reach US$ 26850 million in 2029. The CAGR will be 2.1% during 2024 to 2029.
Globally, Neuroprotective Products key manufacturers include Genervon, NeuroVive Pharmaceutical, Ceregene, BHR Pharma, Neuren Pharmaceuticals, Allon therapeutics and Bionure, etc. Genervon, NeuroVive Pharmaceutical, Ceregene are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Neuroprotective Products were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Neuroprotective Products market and estimated to attract more attentions from industry insiders and investors.
Neuroprotective Products can be divided into Cholinesterase inhibitors, NMDA receptor antagonists and Others,, etc. Cholinesterase inhibitors is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Neuroprotective Products is widely used in various fields, such as Alzheimer's disease, Multiple sclerosis and Others,, etc. Alzheimer's disease provides greatest supports to the Neuroprotective Products industry development. In 2022, global % sales of Neuroprotective Products went into Alzheimer's disease filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Neuroprotective Products market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Neuroprotective Products market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Genervon
NeuroVive Pharmaceutical
Ceregene
BHR Pharma
Neuren Pharmaceuticals
Allon therapeutics
Bionure
Segment by Type
Cholinesterase inhibitors
NMDA receptor antagonists
Others

Segment by Application


Alzheimer's disease
Multiple sclerosis
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Neuroprotective Products plant distribution, commercial date of Neuroprotective Products, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Neuroprotective Products introduction, etc. Neuroprotective Products Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Neuroprotective Products
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Neuroprotective Products Product Introduction
1.2 Market by Type
1.2.1 Global Neuroprotective Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cholinesterase inhibitors
1.2.3 NMDA receptor antagonists
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neuroprotective Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Alzheimer's disease
1.3.3 Multiple sclerosis
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Neuroprotective Products Sales Estimates and Forecasts 2018-2029
2.2 Global Neuroprotective Products Revenue by Region
2.2.1 Global Neuroprotective Products Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Neuroprotective Products Revenue by Region (2018-2024)
2.2.3 Global Neuroprotective Products Revenue by Region (2024-2029)
2.2.4 Global Neuroprotective Products Revenue Market Share by Region (2018-2029)
2.3 Global Neuroprotective Products Sales Estimates and Forecasts 2018-2029
2.4 Global Neuroprotective Products Sales by Region
2.4.1 Global Neuroprotective Products Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Neuroprotective Products Sales by Region (2018-2024)
2.4.3 Global Neuroprotective Products Sales by Region (2024-2029)
2.4.4 Global Neuroprotective Products Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Neuroprotective Products Sales by Manufacturers
3.1.1 Global Neuroprotective Products Sales by Manufacturers (2018-2024)
3.1.2 Global Neuroprotective Products Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neuroprotective Products in 2022
3.2 Global Neuroprotective Products Revenue by Manufacturers
3.2.1 Global Neuroprotective Products Revenue by Manufacturers (2018-2024)
3.2.2 Global Neuroprotective Products Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Neuroprotective Products Revenue in 2022
3.3 Global Key Players of Neuroprotective Products, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Neuroprotective Products Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Neuroprotective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Neuroprotective Products, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Neuroprotective Products, Product Offered and Application
3.8 Global Key Manufacturers of Neuroprotective Products, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neuroprotective Products Sales by Type
4.1.1 Global Neuroprotective Products Historical Sales by Type (2018-2024)
4.1.2 Global Neuroprotective Products Forecasted Sales by Type (2024-2029)
4.1.3 Global Neuroprotective Products Sales Market Share by Type (2018-2029)
4.2 Global Neuroprotective Products Revenue by Type
4.2.1 Global Neuroprotective Products Historical Revenue by Type (2018-2024)
4.2.2 Global Neuroprotective Products Forecasted Revenue by Type (2024-2029)
4.2.3 Global Neuroprotective Products Revenue Market Share by Type (2018-2029)
4.3 Global Neuroprotective Products Price by Type
4.3.1 Global Neuroprotective Products Price by Type (2018-2024)
4.3.2 Global Neuroprotective Products Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Neuroprotective Products Sales by Application
5.1.1 Global Neuroprotective Products Historical Sales by Application (2018-2024)
5.1.2 Global Neuroprotective Products Forecasted Sales by Application (2024-2029)
5.1.3 Global Neuroprotective Products Sales Market Share by Application (2018-2029)
5.2 Global Neuroprotective Products Revenue by Application
5.2.1 Global Neuroprotective Products Historical Revenue by Application (2018-2024)
5.2.2 Global Neuroprotective Products Forecasted Revenue by Application (2024-2029)
5.2.3 Global Neuroprotective Products Revenue Market Share by Application (2018-2029)
5.3 Global Neuroprotective Products Price by Application
5.3.1 Global Neuroprotective Products Price by Application (2018-2024)
5.3.2 Global Neuroprotective Products Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Neuroprotective Products Market Size by Type
6.1.1 US & Canada Neuroprotective Products Sales by Type (2018-2029)
6.1.2 US & Canada Neuroprotective Products Revenue by Type (2018-2029)
6.2 US & Canada Neuroprotective Products Market Size by Application
6.2.1 US & Canada Neuroprotective Products Sales by Application (2018-2029)
6.2.2 US & Canada Neuroprotective Products Revenue by Application (2018-2029)
6.3 US & Canada Neuroprotective Products Market Size by Country
6.3.1 US & Canada Neuroprotective Products Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Neuroprotective Products Sales by Country (2018-2029)
6.3.3 US & Canada Neuroprotective Products Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Neuroprotective Products Market Size by Type
7.1.1 Europe Neuroprotective Products Sales by Type (2018-2029)
7.1.2 Europe Neuroprotective Products Revenue by Type (2018-2029)
7.2 Europe Neuroprotective Products Market Size by Application
7.2.1 Europe Neuroprotective Products Sales by Application (2018-2029)
7.2.2 Europe Neuroprotective Products Revenue by Application (2018-2029)
7.3 Europe Neuroprotective Products Market Size by Country
7.3.1 Europe Neuroprotective Products Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Neuroprotective Products Sales by Country (2018-2029)
7.3.3 Europe Neuroprotective Products Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Neuroprotective Products Market Size
8.1.1 China Neuroprotective Products Sales (2018-2029)
8.1.2 China Neuroprotective Products Revenue (2018-2029)
8.2 China Neuroprotective Products Market Size by Application
8.2.1 China Neuroprotective Products Sales by Application (2018-2029)
8.2.2 China Neuroprotective Products Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Neuroprotective Products Market Size by Type
9.1.1 Asia Neuroprotective Products Sales by Type (2018-2029)
9.1.2 Asia Neuroprotective Products Revenue by Type (2018-2029)
9.2 Asia Neuroprotective Products Market Size by Application
9.2.1 Asia Neuroprotective Products Sales by Application (2018-2029)
9.2.2 Asia Neuroprotective Products Revenue by Application (2018-2029)
9.3 Asia Neuroprotective Products Sales by Region
9.3.1 Asia Neuroprotective Products Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Neuroprotective Products Revenue by Region (2018-2029)
9.3.3 Asia Neuroprotective Products Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Neuroprotective Products Market Size by Type
10.1.1 Middle East, Africa and Latin America Neuroprotective Products Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Neuroprotective Products Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Neuroprotective Products Market Size by Application
10.2.1 Middle East, Africa and Latin America Neuroprotective Products Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Neuroprotective Products Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Neuroprotective Products Sales by Country
10.3.1 Middle East, Africa and Latin America Neuroprotective Products Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Neuroprotective Products Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Neuroprotective Products Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Genervon
11.1.1 Genervon Company Information
11.1.2 Genervon Overview
11.1.3 Genervon Neuroprotective Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Genervon Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Genervon Recent Developments
11.2 NeuroVive Pharmaceutical
11.2.1 NeuroVive Pharmaceutical Company Information
11.2.2 NeuroVive Pharmaceutical Overview
11.2.3 NeuroVive Pharmaceutical Neuroprotective Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 NeuroVive Pharmaceutical Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NeuroVive Pharmaceutical Recent Developments
11.3 Ceregene
11.3.1 Ceregene Company Information
11.3.2 Ceregene Overview
11.3.3 Ceregene Neuroprotective Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Ceregene Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ceregene Recent Developments
11.4 BHR Pharma
11.4.1 BHR Pharma Company Information
11.4.2 BHR Pharma Overview
11.4.3 BHR Pharma Neuroprotective Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 BHR Pharma Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BHR Pharma Recent Developments
11.5 Neuren Pharmaceuticals
11.5.1 Neuren Pharmaceuticals Company Information
11.5.2 Neuren Pharmaceuticals Overview
11.5.3 Neuren Pharmaceuticals Neuroprotective Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Neuren Pharmaceuticals Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Neuren Pharmaceuticals Recent Developments
11.6 Allon therapeutics
11.6.1 Allon therapeutics Company Information
11.6.2 Allon therapeutics Overview
11.6.3 Allon therapeutics Neuroprotective Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Allon therapeutics Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Allon therapeutics Recent Developments
11.7 Bionure
11.7.1 Bionure Company Information
11.7.2 Bionure Overview
11.7.3 Bionure Neuroprotective Products Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Bionure Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bionure Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neuroprotective Products Industry Chain Analysis
12.2 Neuroprotective Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neuroprotective Products Production Mode & Process
12.4 Neuroprotective Products Sales and Marketing
12.4.1 Neuroprotective Products Sales Channels
12.4.2 Neuroprotective Products Distributors
12.5 Neuroprotective Products Customers
13 Market Dynamics
13.1 Neuroprotective Products Industry Trends
13.2 Neuroprotective Products Market Drivers
13.3 Neuroprotective Products Market Challenges
13.4 Neuroprotective Products Market Restraints
14 Key Findings in The Global Neuroprotective Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Neuroprotective Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Cholinesterase inhibitors
Table 3. Major Manufacturers of NMDA receptor antagonists
Table 4. Major Manufacturers of Others
Table 5. Global Neuroprotective Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Neuroprotective Products Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Neuroprotective Products Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Neuroprotective Products Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Neuroprotective Products Revenue Market Share by Region (2018-2024)
Table 10. Global Neuroprotective Products Revenue Market Share by Region (2024-2029)
Table 11. Global Neuroprotective Products Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Neuroprotective Products Sales by Region (2018-2024) & (MT)
Table 13. Global Neuroprotective Products Sales by Region (2024-2029) & (MT)
Table 14. Global Neuroprotective Products Sales Market Share by Region (2018-2024)
Table 15. Global Neuroprotective Products Sales Market Share by Region (2024-2029)
Table 16. Global Neuroprotective Products Sales by Manufacturers (2018-2024) & (MT)
Table 17. Global Neuroprotective Products Sales Share by Manufacturers (2018-2024)
Table 18. Global Neuroprotective Products Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Neuroprotective Products Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Neuroprotective Products, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Neuroprotective Products Price by Manufacturers 2018-2024 (USD/Kg)
Table 22. Global Neuroprotective Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Neuroprotective Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotective Products as of 2022)
Table 24. Global Key Manufacturers of Neuroprotective Products, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Neuroprotective Products, Product Offered and Application
Table 26. Global Key Manufacturers of Neuroprotective Products, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neuroprotective Products Sales by Type (2018-2024) & (MT)
Table 29. Global Neuroprotective Products Sales by Type (2024-2029) & (MT)
Table 30. Global Neuroprotective Products Sales Share by Type (2018-2024)
Table 31. Global Neuroprotective Products Sales Share by Type (2024-2029)
Table 32. Global Neuroprotective Products Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Neuroprotective Products Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Neuroprotective Products Revenue Share by Type (2018-2024)
Table 35. Global Neuroprotective Products Revenue Share by Type (2024-2029)
Table 36. Neuroprotective Products Price by Type (2018-2024) & (USD/Kg)
Table 37. Global Neuroprotective Products Price Forecast by Type (2024-2029) & (USD/Kg)
Table 38. Global Neuroprotective Products Sales by Application (2018-2024) & (MT)
Table 39. Global Neuroprotective Products Sales by Application (2024-2029) & (MT)
Table 40. Global Neuroprotective Products Sales Share by Application (2018-2024)
Table 41. Global Neuroprotective Products Sales Share by Application (2024-2029)
Table 42. Global Neuroprotective Products Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Neuroprotective Products Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Neuroprotective Products Revenue Share by Application (2018-2024)
Table 45. Global Neuroprotective Products Revenue Share by Application (2024-2029)
Table 46. Neuroprotective Products Price by Application (2018-2024) & (USD/Kg)
Table 47. Global Neuroprotective Products Price Forecast by Application (2024-2029) & (USD/Kg)
Table 48. US & Canada Neuroprotective Products Sales by Type (2018-2024) & (MT)
Table 49. US & Canada Neuroprotective Products Sales by Type (2024-2029) & (MT)
Table 50. US & Canada Neuroprotective Products Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Neuroprotective Products Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Neuroprotective Products Sales by Application (2018-2024) & (MT)
Table 53. US & Canada Neuroprotective Products Sales by Application (2024-2029) & (MT)
Table 54. US & Canada Neuroprotective Products Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Neuroprotective Products Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Neuroprotective Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Neuroprotective Products Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Neuroprotective Products Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Neuroprotective Products Sales by Country (2018-2024) & (MT)
Table 60. US & Canada Neuroprotective Products Sales by Country (2024-2029) & (MT)
Table 61. Europe Neuroprotective Products Sales by Type (2018-2024) & (MT)
Table 62. Europe Neuroprotective Products Sales by Type (2024-2029) & (MT)
Table 63. Europe Neuroprotective Products Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Neuroprotective Products Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Neuroprotective Products Sales by Application (2018-2024) & (MT)
Table 66. Europe Neuroprotective Products Sales by Application (2024-2029) & (MT)
Table 67. Europe Neuroprotective Products Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Neuroprotective Products Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Neuroprotective Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Neuroprotective Products Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Neuroprotective Products Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Neuroprotective Products Sales by Country (2018-2024) & (MT)
Table 73. Europe Neuroprotective Products Sales by Country (2024-2029) & (MT)
Table 74. China Neuroprotective Products Sales by Type (2018-2024) & (MT)
Table 75. China Neuroprotective Products Sales by Type (2024-2029) & (MT)
Table 76. China Neuroprotective Products Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Neuroprotective Products Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Neuroprotective Products Sales by Application (2018-2024) & (MT)
Table 79. China Neuroprotective Products Sales by Application (2024-2029) & (MT)
Table 80. China Neuroprotective Products Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Neuroprotective Products Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Neuroprotective Products Sales by Type (2018-2024) & (MT)
Table 83. Asia Neuroprotective Products Sales by Type (2024-2029) & (MT)
Table 84. Asia Neuroprotective Products Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Neuroprotective Products Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Neuroprotective Products Sales by Application (2018-2024) & (MT)
Table 87. Asia Neuroprotective Products Sales by Application (2024-2029) & (MT)
Table 88. Asia Neuroprotective Products Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Neuroprotective Products Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Neuroprotective Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Neuroprotective Products Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Neuroprotective Products Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Neuroprotective Products Sales by Region (2018-2024) & (MT)
Table 94. Asia Neuroprotective Products Sales by Region (2024-2029) & (MT)
Table 95. Middle East, Africa and Latin America Neuroprotective Products Sales by Type (2018-2024) & (MT)
Table 96. Middle East, Africa and Latin America Neuroprotective Products Sales by Type (2024-2029) & (MT)
Table 97. Middle East, Africa and Latin America Neuroprotective Products Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Neuroprotective Products Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Neuroprotective Products Sales by Application (2018-2024) & (MT)
Table 100. Middle East, Africa and Latin America Neuroprotective Products Sales by Application (2024-2029) & (MT)
Table 101. Middle East, Africa and Latin America Neuroprotective Products Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Neuroprotective Products Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Neuroprotective Products Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Neuroprotective Products Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Neuroprotective Products Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Neuroprotective Products Sales by Country (2018-2024) & (MT)
Table 107. Middle East, Africa and Latin America Neuroprotective Products Sales by Country (2024-2029) & (MT)
Table 108. Genervon Company Information
Table 109. Genervon Description and Major Businesses
Table 110. Genervon Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 111. Genervon Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Genervon Recent Developments
Table 113. NeuroVive Pharmaceutical Company Information
Table 114. NeuroVive Pharmaceutical Description and Major Businesses
Table 115. NeuroVive Pharmaceutical Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 116. NeuroVive Pharmaceutical Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. NeuroVive Pharmaceutical Recent Developments
Table 118. Ceregene Company Information
Table 119. Ceregene Description and Major Businesses
Table 120. Ceregene Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 121. Ceregene Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Ceregene Recent Developments
Table 123. BHR Pharma Company Information
Table 124. BHR Pharma Description and Major Businesses
Table 125. BHR Pharma Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 126. BHR Pharma Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. BHR Pharma Recent Developments
Table 128. Neuren Pharmaceuticals Company Information
Table 129. Neuren Pharmaceuticals Description and Major Businesses
Table 130. Neuren Pharmaceuticals Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 131. Neuren Pharmaceuticals Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Neuren Pharmaceuticals Recent Developments
Table 133. Allon therapeutics Company Information
Table 134. Allon therapeutics Description and Major Businesses
Table 135. Allon therapeutics Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 136. Allon therapeutics Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Allon therapeutics Recent Developments
Table 138. Bionure Company Information
Table 139. Bionure Description and Major Businesses
Table 140. Bionure Neuroprotective Products Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 141. Bionure Neuroprotective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Bionure Recent Developments
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Neuroprotective Products Distributors List
Table 146. Neuroprotective Products Customers List
Table 147. Neuroprotective Products Market Trends
Table 148. Neuroprotective Products Market Drivers
Table 149. Neuroprotective Products Market Challenges
Table 150. Neuroprotective Products Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuroprotective Products Product Picture
Figure 2. Global Neuroprotective Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Neuroprotective Products Market Share by Type in 2022 & 2029
Figure 4. Cholinesterase inhibitors Product Picture
Figure 5. NMDA receptor antagonists Product Picture
Figure 6. Others Product Picture
Figure 7. Global Neuroprotective Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Neuroprotective Products Market Share by Application in 2022 & 2029
Figure 9. Alzheimer's disease
Figure 10. Multiple sclerosis
Figure 11. Others
Figure 12. Neuroprotective Products Report Years Considered
Figure 13. Global Neuroprotective Products Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Neuroprotective Products Revenue 2018-2029 (US$ Million)
Figure 15. Global Neuroprotective Products Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Neuroprotective Products Revenue Market Share by Region (2018-2029)
Figure 17. Global Neuroprotective Products Sales 2018-2029 ((MT)
Figure 18. Global Neuroprotective Products Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Neuroprotective Products Sales YoY (2018-2029) & (MT)
Figure 20. US & Canada Neuroprotective Products Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Neuroprotective Products Sales YoY (2018-2029) & (MT)
Figure 22. Europe Neuroprotective Products Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Neuroprotective Products Sales YoY (2018-2029) & (MT)
Figure 24. China Neuroprotective Products Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Neuroprotective Products Sales YoY (2018-2029) & (MT)
Figure 26. Asia (excluding China) Neuroprotective Products Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Neuroprotective Products Sales YoY (2018-2029) & (MT)
Figure 28. Middle East, Africa and Latin America Neuroprotective Products Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Neuroprotective Products Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Neuroprotective Products in the World: Market Share by Neuroprotective Products Revenue in 2022
Figure 31. Global Neuroprotective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Neuroprotective Products Sales Market Share by Type (2018-2029)
Figure 33. Global Neuroprotective Products Revenue Market Share by Type (2018-2029)
Figure 34. Global Neuroprotective Products Sales Market Share by Application (2018-2029)
Figure 35. Global Neuroprotective Products Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Neuroprotective Products Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Neuroprotective Products Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Neuroprotective Products Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Neuroprotective Products Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Neuroprotective Products Revenue Share by Country (2018-2029)
Figure 41. US & Canada Neuroprotective Products Sales Share by Country (2018-2029)
Figure 42. U.S. Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Neuroprotective Products Sales Market Share by Type (2018-2029)
Figure 45. Europe Neuroprotective Products Revenue Market Share by Type (2018-2029)
Figure 46. Europe Neuroprotective Products Sales Market Share by Application (2018-2029)
Figure 47. Europe Neuroprotective Products Revenue Market Share by Application (2018-2029)
Figure 48. Europe Neuroprotective Products Revenue Share by Country (2018-2029)
Figure 49. Europe Neuroprotective Products Sales Share by Country (2018-2029)
Figure 50. Germany Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 51. France Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 55. China Neuroprotective Products Sales Market Share by Type (2018-2029)
Figure 56. China Neuroprotective Products Revenue Market Share by Type (2018-2029)
Figure 57. China Neuroprotective Products Sales Market Share by Application (2018-2029)
Figure 58. China Neuroprotective Products Revenue Market Share by Application (2018-2029)
Figure 59. Asia Neuroprotective Products Sales Market Share by Type (2018-2029)
Figure 60. Asia Neuroprotective Products Revenue Market Share by Type (2018-2029)
Figure 61. Asia Neuroprotective Products Sales Market Share by Application (2018-2029)
Figure 62. Asia Neuroprotective Products Revenue Market Share by Application (2018-2029)
Figure 63. Asia Neuroprotective Products Revenue Share by Region (2018-2029)
Figure 64. Asia Neuroprotective Products Sales Share by Region (2018-2029)
Figure 65. Japan Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 69. India Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Neuroprotective Products Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Neuroprotective Products Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Neuroprotective Products Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Neuroprotective Products Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Neuroprotective Products Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Neuroprotective Products Sales Share by Country (2018-2029)
Figure 76. Brazil Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Neuroprotective Products Revenue (2018-2029) & (US$ Million)
Figure 81. Neuroprotective Products Value Chain
Figure 82. Neuroprotective Products Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries